Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors.

Radnai L, Stremel RF, Sellers JR, Rumbaugh G, Miller CA.

J Vis Exp. 2019 Aug 17;(150). doi: 10.3791/60017.

PMID:
31475972
2.

microRNA mir-598-3p mediates susceptibility to stress enhancement of remote fear memory.

Jones ME, Sillivan SE, Jamieson S, Rumbaugh G, Miller CA.

Learn Mem. 2019 Aug 15;26(9):363-372. doi: 10.1101/lm.048827.118. Print 2019 Sep.

PMID:
31416909
3.

Correction: MicroRNA regulation of persistent stress-enhanced memory.

Sillivan SE, Jamieson S, de Nijs L, Jones M, Snijders C, Klengel T, Joseph NF, Krauskopf J, Kleinjans J, Vinkers CH, Boks MPM, Geuze E, Vermetten E, Berretta S, Ressler KJ, Rutten BPF, Rumbaugh G, Miller CA.

Mol Psychiatry. 2019 Jun 28. doi: 10.1038/s41380-019-0452-y. [Epub ahead of print]

PMID:
31253953
4.

A Simple Procedure for Creating Scalable Phenotypic Screening Assays in Human Neurons.

Sridharan B, Hubbs C, Llamosas N, Kilinc M, Singhera FU, Willems E, Piper DR, Scampavia L, Rumbaugh G, Spicer TP.

Sci Rep. 2019 Jun 21;9(1):9000. doi: 10.1038/s41598-019-45265-1.

5.

MicroRNA regulation of persistent stress-enhanced memory.

Sillivan SE, Jamieson S, de Nijs L, Jones M, Snijders C, Klengel T, Joseph NF, Krauskopf J, Kleinjans J, Vinkers CH, Boks MPM, Geuze E, Vermetten E, Berretta S, Ressler KJ, Rutten BPF, Rumbaugh G, Miller CA.

Mol Psychiatry. 2019 May 29. doi: 10.1038/s41380-019-0432-2. [Epub ahead of print] Erratum in: Mol Psychiatry. 2019 Jun 28;:.

PMID:
31142820
6.

Re-expression of SynGAP protein in adulthood improves translatable measures of brain function and behavior.

Creson TK, Rojas C, Hwaun E, Vaissiere T, Kilinc M, Jimenez-Gomez A, Holder JL Jr, Tang J, Colgin LL, Miller CA, Rumbaugh G.

Elife. 2019 Apr 26;8. pii: e46752. doi: 10.7554/eLife.46752.

7.

Bioinformatic analysis of long-lasting transcriptional and translational changes in the basolateral amygdala following acute stress.

Sillivan SE, Jones ME, Jamieson S, Rumbaugh G, Miller CA.

PLoS One. 2019 Jan 10;14(1):e0209846. doi: 10.1371/journal.pone.0209846. eCollection 2019.

8.

SYNGAP1 heterozygosity disrupts sensory processing by reducing touch-related activity within somatosensory cortex circuits.

Michaelson SD, Ozkan ED, Aceti M, Maity S, Llamosas N, Weldon M, Mizrachi E, Vaissiere T, Gaffield MA, Christie JM, Holder JL Jr, Miller CA, Rumbaugh G.

Nat Neurosci. 2018 Dec;21(12):1-13. doi: 10.1038/s41593-018-0268-0. Epub 2018 Nov 21.

9.

The role of nonmuscle myosin II in polydrug memories and memory reconsolidation.

Briggs SB, Hafenbreidel M, Young EJ, Rumbaugh G, Miller CA.

Learn Mem. 2018 Aug 16;25(9):391-398. doi: 10.1101/lm.046763.117. Print 2018 Sep.

10.

Social stress-potentiated methamphetamine seeking.

Blouin AM, Pisupati S, Hoffer CG, Hafenbreidel M, Jamieson SE, Rumbaugh G, Miller CA.

Addict Biol. 2019 Sep;24(5):958-968. doi: 10.1111/adb.12666. Epub 2018 Aug 14.

PMID:
30105771
11.

Improved Scalability of Neuron-Based Phenotypic Screening Assays for Therapeutic Discovery in Neuropsychiatric Disorders.

Spicer TP, Hubbs C, Vaissiere T, Collia D, Rojas C, Kilinc M, Vick K, Madoux F, Baillargeon P, Shumate J, Martemyanov KA, Page DT, Puthanveettil S, Hodder P, Davis R, Miller CA, Scampavia L, Rumbaugh G.

Mol Neuropsychiatry. 2018 Feb;3(3):141-150. doi: 10.1159/000481731. Epub 2017 Nov 17.

12.

Species-conserved SYNGAP1 phenotypes associated with neurodevelopmental disorders.

Kilinc M, Creson T, Rojas C, Aceti M, Ellegood J, Vaissiere T, Lerch JP, Rumbaugh G.

Mol Cell Neurosci. 2018 Sep;91:140-150. doi: 10.1016/j.mcn.2018.03.008. Epub 2018 Mar 24. Review.

13.

The first international conference on SYNGAP1-related brain disorders: a stakeholder meeting of families, researchers, clinicians, and regulators.

Weldon M, Kilinc M, Lloyd Holder J Jr, Rumbaugh G.

J Neurodev Disord. 2018 Feb 5;10(1):6. doi: 10.1186/s11689-018-9225-1. Review.

14.

Publisher Correction: An interactive framework for whole-brain maps at cellular resolution.

Fürth D, Vaissière T, Tzortzi O, Xuan Y, Märtin A, Lazaridis I, Spigolon G, Fisone G, Tomer R, Deisseroth K, Carlén M, Miller CA, Rumbaugh G, Meletis K.

Nat Neurosci. 2018 Jun;21(6):895. doi: 10.1038/s41593-017-0058-0.

PMID:
29255166
15.

An interactive framework for whole-brain maps at cellular resolution.

Fürth D, Vaissière T, Tzortzi O, Xuan Y, Märtin A, Lazaridis I, Spigolon G, Fisone G, Tomer R, Deisseroth K, Carlén M, Miller CA, Rumbaugh G, Meletis K.

Nat Neurosci. 2018 Jan;21(1):139-149. doi: 10.1038/s41593-017-0027-7. Epub 2017 Dec 4. Erratum in: Nat Neurosci. 2017 Dec 18;:.

16.

Susceptibility and Resilience to Posttraumatic Stress Disorder-like Behaviors in Inbred Mice.

Sillivan SE, Joseph NF, Jamieson S, King ML, Chévere-Torres I, Fuentes I, Shumyatsky GP, Brantley AF, Rumbaugh G, Miller CA.

Biol Psychiatry. 2017 Dec 15;82(12):924-933. doi: 10.1016/j.biopsych.2017.06.030. Epub 2017 Jul 8.

17.

Atypical Endocannabinoid Signaling Initiates a New Form of Memory-Related Plasticity at a Cortical Input to Hippocampus.

Wang W, Jia Y, Pham DT, Palmer LC, Jung KM, Cox CD, Rumbaugh G, Piomelli D, Gall CM, Lynch G.

Cereb Cortex. 2018 Jul 1;28(7):2253-2266. doi: 10.1093/cercor/bhx126.

18.

Memory disrupting effects of nonmuscle myosin II inhibition depend on the class of abused drug and brain region.

Briggs SB, Blouin AM, Young EJ, Rumbaugh G, Miller CA.

Learn Mem. 2017 Jan 17;24(2):70-75. doi: 10.1101/lm.043976.116. Print 2017 Feb.

19.

Nonmuscle myosin II inhibition disrupts methamphetamine-associated memory in females and adolescents.

Young EJ, Briggs SB, Rumbaugh G, Miller CA.

Neurobiol Learn Mem. 2017 Mar;139:109-116. doi: 10.1016/j.nlm.2017.01.001. Epub 2017 Jan 7.

20.

Nonmuscle myosin IIB as a therapeutic target for the prevention of relapse to methamphetamine use.

Young EJ, Blouin AM, Briggs SB, Sillivan SE, Lin L, Cameron MD, Rumbaugh G, Miller CA.

Mol Psychiatry. 2016 May;21(5):615-23. doi: 10.1038/mp.2015.103. Epub 2015 Aug 4.

21.

Prioritizing the development of mouse models for childhood brain disorders.

Ogden KK, Ozkan ED, Rumbaugh G.

Neuropharmacology. 2016 Jan;100:2-16. doi: 10.1016/j.neuropharm.2015.07.029. Epub 2015 Jul 29. Review.

22.

Input-specific regulation of hippocampal circuit maturation by non-muscle myosin IIB.

Ozkan ED, Aceti M, Creson TK, Rojas CS, Hubbs CR, McGuire MN, Kakad PP, Miller CA, Rumbaugh G.

J Neurochem. 2015 Aug;134(3):429-44. doi: 10.1111/jnc.13146. Epub 2015 May 29.

23.

Pharmacological Selectivity Within Class I Histone Deacetylases Predicts Effects on Synaptic Function and Memory Rescue.

Rumbaugh G, Sillivan SE, Ozkan ED, Rojas CS, Hubbs CR, Aceti M, Kilgore M, Kudugunti S, Puthanveettil SV, Sweatt JD, Rusche J, Miller CA.

Neuropsychopharmacology. 2015 Sep;40(10):2307-16. doi: 10.1038/npp.2015.93. Epub 2015 Apr 3.

24.

Neuronal death induced by misfolded prion protein is due to NAD+ depletion and can be relieved in vitro and in vivo by NAD+ replenishment.

Zhou M, Ottenberg G, Sferrazza GF, Hubbs C, Fallahi M, Rumbaugh G, Brantley AF, Lasmézas CI.

Brain. 2015 Apr;138(Pt 4):992-1008. doi: 10.1093/brain/awv002. Epub 2015 Feb 11.

25.

Syngap1 haploinsufficiency damages a postnatal critical period of pyramidal cell structural maturation linked to cortical circuit assembly.

Aceti M, Creson TK, Vaissiere T, Rojas C, Huang WC, Wang YX, Petralia RS, Page DT, Miller CA, Rumbaugh G.

Biol Psychiatry. 2015 May 1;77(9):805-15. doi: 10.1016/j.biopsych.2014.08.001. Epub 2014 Aug 13.

26.

Reduced cognition in Syngap1 mutants is caused by isolated damage within developing forebrain excitatory neurons.

Ozkan ED, Creson TK, Kramár EA, Rojas C, Seese RR, Babyan AH, Shi Y, Lucero R, Xu X, Noebels JL, Miller CA, Lynch G, Rumbaugh G.

Neuron. 2014 Jun 18;82(6):1317-33. doi: 10.1016/j.neuron.2014.05.015.

27.

Methamphetamine-associated memory is regulated by a writer and an eraser of permissive histone methylation.

Aguilar-Valles A, Vaissière T, Griggs EM, Mikaelsson MA, Takács IF, Young EJ, Rumbaugh G, Miller CA.

Biol Psychiatry. 2014 Jul 1;76(1):57-65. doi: 10.1016/j.biopsych.2013.09.014. Epub 2013 Oct 31.

28.

Selective, retrieval-independent disruption of methamphetamine-associated memory by actin depolymerization.

Young EJ, Aceti M, Griggs EM, Fuchs RA, Zigmond Z, Rumbaugh G, Miller CA.

Biol Psychiatry. 2014 Jan 15;75(2):96-104. doi: 10.1016/j.biopsych.2013.07.036. Epub 2013 Sep 5.

29.

SYNGAP1 links the maturation rate of excitatory synapses to the duration of critical-period synaptic plasticity.

Clement JP, Ozkan ED, Aceti M, Miller CA, Rumbaugh G.

J Neurosci. 2013 Jun 19;33(25):10447-52. doi: 10.1523/JNEUROSCI.0765-13.2013.

30.

MicroRNA-182 regulates amygdala-dependent memory formation.

Griggs EM, Young EJ, Rumbaugh G, Miller CA.

J Neurosci. 2013 Jan 23;33(4):1734-40. doi: 10.1523/JNEUROSCI.2873-12.2013.

31.

Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses.

Clement JP, Aceti M, Creson TK, Ozkan ED, Shi Y, Reish NJ, Almonte AG, Miller BH, Wiltgen BJ, Miller CA, Xu X, Rumbaugh G.

Cell. 2012 Nov 9;151(4):709-723. doi: 10.1016/j.cell.2012.08.045.

32.

Protease-activated receptor-1 modulates hippocampal memory formation and synaptic plasticity.

Almonte AG, Qadri LH, Sultan FA, Watson JA, Mount DJ, Rumbaugh G, Sweatt JD.

J Neurochem. 2013 Jan;124(1):109-22. doi: 10.1111/jnc.12075. Epub 2012 Nov 21.

33.

Differences between synaptic plasticity thresholds result in new timing rules for maximizing long-term potentiation.

Lynch G, Kramár EA, Babayan AH, Rumbaugh G, Gall CM.

Neuropharmacology. 2013 Jan;64:27-36. doi: 10.1016/j.neuropharm.2012.07.006. Epub 2012 Jul 20. Review.

34.

Synaptic evidence for the efficacy of spaced learning.

Kramár EA, Babayan AH, Gavin CF, Cox CD, Jafari M, Gall CM, Rumbaugh G, Lynch G.

Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):5121-6. doi: 10.1073/pnas.1120700109. Epub 2012 Mar 12.

35.

Myosin II motor activity in the lateral amygdala is required for fear memory consolidation.

Gavin CF, Rubio MD, Young E, Miller C, Rumbaugh G.

Learn Mem. 2011 Dec 14;19(1):9-14. doi: 10.1101/lm.024042.111. Print 2012 Jan.

36.

Regulation of synapse structure and function by distinct myosin II motors.

Rubio MD, Johnson R, Miller CA, Huganir RL, Rumbaugh G.

J Neurosci. 2011 Jan 26;31(4):1448-60. doi: 10.1523/JNEUROSCI.3294-10.2011.

37.

Epigenetic changes in the brain: measuring global histone modifications.

Rumbaugh G, Miller CA.

Methods Mol Biol. 2011;670:263-74. doi: 10.1007/978-1-60761-744-0_18.

38.

Myosin IIb regulates actin dynamics during synaptic plasticity and memory formation.

Rex CS, Gavin CF, Rubio MD, Kramar EA, Chen LY, Jia Y, Huganir RL, Muzyczka N, Gall CM, Miller CA, Lynch G, Rumbaugh G.

Neuron. 2010 Aug 26;67(4):603-17. doi: 10.1016/j.neuron.2010.07.016.

39.

Cortical DNA methylation maintains remote memory.

Miller CA, Gavin CF, White JA, Parrish RR, Honasoge A, Yancey CR, Rivera IM, Rubio MD, Rumbaugh G, Sweatt JD.

Nat Neurosci. 2010 Jun;13(6):664-6. doi: 10.1038/nn.2560. Epub 2010 May 23.

40.

Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease.

Kilgore M, Miller CA, Fass DM, Hennig KM, Haggarty SJ, Sweatt JD, Rumbaugh G.

Neuropsychopharmacology. 2010 Mar;35(4):870-80. doi: 10.1038/npp.2009.197. Epub 2009 Dec 9.

41.

Decreased expression of NMDA receptor-associated proteins in frontal cortex of elderly patients with schizophrenia.

Funk AJ, Rumbaugh G, Harotunian V, McCullumsmith RE, Meador-Woodruff JH.

Neuroreport. 2009 Jul 15;20(11):1019-22. doi: 10.1097/WNR.0b013e32832d30d9.

42.

Reduced expression of the NMDA receptor-interacting protein SynGAP causes behavioral abnormalities that model symptoms of Schizophrenia.

Guo X, Hamilton PJ, Reish NJ, Sweatt JD, Miller CA, Rumbaugh G.

Neuropsychopharmacology. 2009 Jun;34(7):1659-72. doi: 10.1038/npp.2008.223. Epub 2009 Jan 14.

43.

Surface mobility of postsynaptic AMPARs tunes synaptic transmission.

Heine M, Groc L, Frischknecht R, Béïque JC, Lounis B, Rumbaugh G, Huganir RL, Cognet L, Choquet D.

Science. 2008 Apr 11;320(5873):201-5. doi: 10.1126/science.1152089.

44.

Mutations in ionotropic AMPA receptor 3 alter channel properties and are associated with moderate cognitive impairment in humans.

Wu Y, Arai AC, Rumbaugh G, Srivastava AK, Turner G, Hayashi T, Suzuki E, Jiang Y, Zhang L, Rodriguez J, Boyle J, Tarpey P, Raymond FL, Nevelsteen J, Froyen G, Stratton M, Futreal A, Gecz J, Stevenson R, Schwartz CE, Valle D, Huganir RL, Wang T.

Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18163-8. Epub 2007 Nov 7.

45.

Interaction of the N-terminal domain of the AMPA receptor GluR4 subunit with the neuronal pentraxin NP1 mediates GluR4 synaptic recruitment.

Sia GM, Béïque JC, Rumbaugh G, Cho R, Worley PF, Huganir RL.

Neuron. 2007 Jul 5;55(1):87-102. Erratum in: Neuron. 2007 Aug 2;55(3):533.

46.

Arc/Arg3.1 mediates homeostatic synaptic scaling of AMPA receptors.

Shepherd JD, Rumbaugh G, Wu J, Chowdhury S, Plath N, Kuhl D, Huganir RL, Worley PF.

Neuron. 2006 Nov 9;52(3):475-84.

47.

SynGAP regulates synaptic strength and mitogen-activated protein kinases in cultured neurons.

Rumbaugh G, Adams JP, Kim JH, Huganir RL.

Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4344-51. Epub 2006 Mar 14.

48.

Ribosomal S6 kinase 2 interacts with and phosphorylates PDZ domain-containing proteins and regulates AMPA receptor transmission.

Thomas GM, Rumbaugh GR, Harrar DB, Huganir RL.

Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15006-11. Epub 2005 Oct 10.

49.

Synapses fight over glutamate receptor 1.

Rumbaugh G.

J Neurosci. 2005 Sep 14;25(37):8347-8. No abstract available.

50.

Supplemental Content

Loading ...
Support Center